$209.95
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Country

US

CEO

Mr. Javier Rodriguez

IPO date

1995

Employees

78,000

ISIN

US23918K1088

Key stats

Open

$207.03

Volume

937.03K

Market cap

$13.40B

Prev. close

$208.66

Impl / hst vl

-

Open interest

$0.00

$204.98

Day’s Range

$210.59

$101.00

52W Range

$211.80

Valuation

33
Valuation score
Overvalued
P/E
13.14
P/S
0.74
P/B
-
Current ratio
1.42
Debt / Equity
-
ROE
-
Gross margin
31.42%
Income growth
-15.66%
FCF growth
-44.65

Analysts estimates

Consensus rating
Buy

The average rating from top 6 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$192.03
The top 10 analysts forecasts that 12-month price may decrease by 8.54%, with a low of $146.45 and a high of $246.75
$146.45
Low
$192.03
Avg
$246.75
High
Current price

Earnings

Q1 ‘26 revenue
$3.42B
Q1 ‘26 net income
$197.53M
Revenue
Net income
Previous EPS
$3.40
Estimate EPS
$2.34
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply